Through single-cell technology, a study systematically analyzed tumor-infiltrating B cells at various stages of colorectal cancer and identified a novel subset of B cells (LARS B) characterized by high expression of leucyl-tRNA synthetase 2 (LARS2). This evidence concerns the gene LARS2 and colorectal cancer.